Ngo, Preston http://orcid.org/0000-0001-5453-0734
Karikios, Deme
Goldsbury, David
Wade, Stephen
Lwin, Zarnie
Hughes, Brett G. M.
Fong, Kwun M.
Canfell, Karen
Weber, Marianne
Funding for this research was provided by:
Department of Health and Aged Care, Australian Government (MRF1200535)
University of Sydney
Article History
Accepted: 30 May 2023
First Online: 25 June 2023
Declarations
:
: This work was funded by a Medical Research Future Fund Preventive and Public Health Research Initiative: 2019 Target Health System and Community Organisation Research Grant Opportunity, No. MRF1200535.
: Karen Canfell is a co-principal investigator of an investigator-initiated trial of cervical screening, “Compass”, run by the Australian Centre for Prevention of Cervical Cancer (ACPCC), which is a government-funded not-for-profit charity. Compass receives infrastructure support from the Australian government and the ACPCC has received equipment and a funding contribution from Roche Molecular Diagnostics, USA. Karen Canfell is also a co-principal investigator on a major implementation program Elimination of Cervical Cancer in the Western Pacific, which has received support from the Minderoo Foundation and the Frazer Family Foundation and equipment donations from Cepheid Inc. Zarnie Lwin declares participation on advisory boards/scientific advisory committees for, travel support from, and/or honoraria from Pfizer, AstraZeneca, Bristol Myers Squibb and Merck. Kwun M. Fong, David Goldsbury, Brett G.M. Hughes, Deme Karikios, Preston Ngo, Marianne Weber and Stephen Wade have no conflicts of interest that are directly relevant to the content of this article.
: Not applicable.
: Not applicable.
: Not applicable.
: Data from the 45 and Up Study used in this study cannot be made available by the authors on grounds of confidentiality and privacy. The data are available from the data custodians (Sax Institute, Services Australia, NSW Ministry of Health) for approved research projects. Enquiries can be made to the Sax Institute (see ExternalRef removed). Molecular tumour datasets used in this study are available on cBioPortal (see ExternalRef removed).
: Not applicable.
: Conceptualisation: PN; methodology: PN, DK, SW, ZL, BH; software: PN; validation: PN; analysis: PN, DG; original draft: PN, MW; review and editing: DK, DG, SW, ZL, BH, KF, KC; supervision: KC, MW.